33
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Species-level functional profiling of metagenomes and metatranscriptomes

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Functional profiling from metagenomic or metatranscriptomic (“meta’omic”) sequencing provides insight into the molecular activities of microbial communities. These analyses are typically carried out using comprehensive search of sequencing reads, which is time-consuming, prone to spurious mapping, and often limited to community-level quantification. We developed a tiered meta’omic search strategy (HUMAnN2) which enables fast, accurate, and species-resolved functional profiling of host-associated and environmental communities. HUMAnN2 identifies a community’s known species, aligns reads to their pangenomes, performs translated search on unclassified reads, and finally quantifies gene families and pathways. Relative to pure translated search, HUMAnN2 is 3x faster and produces more accurate gene family profiles (89% vs. 67%). We apply HUMAnN2 to clinal variation in marine metabolism, ecological contribution patterns among human microbiome pathways, variation in species’ genomic vs. transcriptional contributions, and strain profiling. Finally, we introduce “contributional diversity” to explain patterns of ecological assembly across different microbial community types.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          ART: a next-generation sequencing read simulator.

          ART is a set of simulation tools that generate synthetic next-generation sequencing reads. This functionality is essential for testing and benchmarking tools for next-generation sequencing data analysis including read alignment, de novo assembly and genetic variation discovery. ART generates simulated sequencing reads by emulating the sequencing process with built-in, technology-specific read error models and base quality value profiles parameterized empirically in large sequencing datasets. We currently support all three major commercial next-generation sequencing platforms: Roche's 454, Illumina's Solexa and Applied Biosystems' SOLiD. ART also allows the flexibility to use customized read error model parameters and quality profiles. Both source and binary software packages are available at http://www.niehs.nih.gov/research/resources/software/art.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The microbial pan-genome.

            A decade after the beginning of the genomic era, the question of how genomics can describe a bacterial species has not been fully addressed. Experimental data have shown that in some species new genes are discovered even after sequencing the genomes of several strains. Mathematical modeling predicts that new genes will be discovered even after sequencing hundreds of genomes per species. Therefore, a bacterial species can be described by its pan-genome, which is composed of a "core genome" containing genes present in all strains, and a "dispensable genome" containing genes present in two or more strains and genes unique to single strains. Given that the number of unique genes is vast, the pan-genome of a bacterial species might be orders of magnitude larger than any single genome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Relating the metatranscriptome and metagenome of the human gut.

              Although the composition of the human microbiome is now well-studied, the microbiota's >8 million genes and their regulation remain largely uncharacterized. This knowledge gap is in part because of the difficulty of acquiring large numbers of samples amenable to functional studies of the microbiota. We conducted what is, to our knowledge, one of the first human microbiome studies in a well-phenotyped prospective cohort incorporating taxonomic, metagenomic, and metatranscriptomic profiling at multiple body sites using self-collected samples. Stool and saliva were provided by eight healthy subjects, with the former preserved by three different methods (freezing, ethanol, and RNAlater) to validate self-collection. Within-subject microbial species, gene, and transcript abundances were highly concordant across sampling methods, with only a small fraction of transcripts (<5%) displaying between-method variation. Next, we investigated relationships between the oral and gut microbial communities, identifying a subset of abundant oral microbes that routinely survive transit to the gut, but with minimal transcriptional activity there. Finally, systematic comparison of the gut metagenome and metatranscriptome revealed that a substantial fraction (41%) of microbial transcripts were not differentially regulated relative to their genomic abundances. Of the remainder, consistently underexpressed pathways included sporulation and amino acid biosynthesis, whereas up-regulated pathways included ribosome biogenesis and methanogenesis. Across subjects, metatranscriptional profiles were significantly more individualized than DNA-level functional profiles, but less variable than microbial composition, indicative of subject-specific whole-community regulation. The results thus detail relationships between community genomic potential and gene expression in the gut, and establish the feasibility of metatranscriptomic investigations in subject-collected and shipped samples.
                Bookmark

                Author and article information

                Journal
                101215604
                32338
                Nat Methods
                Nat. Methods
                Nature methods
                1548-7091
                1548-7105
                1 October 2018
                30 October 2018
                November 2018
                30 April 2019
                : 15
                : 11
                : 962-968
                Affiliations
                [1 ]Dept. of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA
                [2 ]The Broad Institute of MIT and Harvard, Cambridge, MA, USA
                [3 ]Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA
                [4 ]Dept. of Pediatrics, University of California San Diego, San Diego, CA, USA
                [5 ]Dept. of Computer Science & Engineering, University of California San Diego, San Diego, CA, USA
                [6 ]Centre for Integrative Biology, University of Trento, Trento, Italy
                Author notes

                AUTHOR CONTRIBUTIONS

                E.A.F., L.J.M., and C.H. designed the methods. L.J.M. developed the software implementation. G.R., G.W., and N.S. produced datasets to support the software. E.A.F., L.J.M., G.R., L.R.T., M.S., and K.S.L. designed and carried out the evaluations and applications; all authors participated in interpretation of the resulting data. E.A.F., L.J.M., L.R.T., M.S., K.S.L., and C.H. wrote the paper with feedback from the other authors.

                []Corresponding author: chuttenh@ 123456hsph.harvard.edu
                Article
                NIHMS1507068
                10.1038/s41592-018-0176-y
                6235447
                30377376
                0bcebbdb-8518-408b-a4cc-87defcb8a122

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Life sciences
                Life sciences

                Comments

                Comment on this article